5 Best Dividend Stocks According to Billionaire Larry Robbins’ Glenview Capital

Page 5 of 5

1. Organon & Co. (NYSE:OGN)

Number of Hedge Fund Holders: 35
Dividend Yield as of February 9: 3.28%
Glenview Capital’s Stake Value: $24,695,000

Organon & Co. (NYSE:OGN), an American pharmaceutical company, was one of the latest acquisitions of Glenview Capital in Q3. The hedge fund started building its position in the company with shares worth roughly $24.7 million, which represented 0.45% of Larry Robbins’ portfolio.

In August 2021, Organon & Co. (NYSE:OGN) initiated its dividend policy, paying a quarterly dividend of $0.28 per share, with a dividend yield of 3.28%. The company’s payout ratio stands at 8.79%, which is considered healthy by analysts. As of the market close of February 8, Organon & Co. (NYSE:OGN) delivered an 11.04% return to shareholders in 2022 so far.

The number of hedge funds tracked by Insider Monkey having stakes in Organon & Co. (NYSE:OGN) declined to 35 in Q3, from 44 in the previous quarter. These stakes hold a consolidated value of over $332.3 million. Among these hedge funds, AQR Capital Management held the largest stake in the company, worth over $71.2 million.

You can also take a look at 10 Best Gun Stocks to Invest In and 15 Best Semiconductor Stocks to Buy Now

Page 5 of 5